Heart Failure Management
Introduction to Beta-Blockers
- Metoprolol tartrate 100mg twice daily is equivalent to metoprolol succinate 200mg once daily, based on total daily dose, as recommended by the American Heart Association and American College of Cardiology 1, 2
Dosage and Administration
- The conversion between metoprolol tartrate and metoprolol succinate is straightforward, with metoprolol tartrate 100mg BID equal to 200mg total daily dose, and equivalent metoprolol succinate dose being 200mg once daily 2
- The standard dosing for metoprolol succinate is 50-400 mg once daily for hypertension, and 12.5-25 mg once daily (target 200 mg once daily) for heart failure, as outlined in the table below 3
| Parameter | Metoprolol Succinate | Metoprolol Tartrate |
|---|---|---|
| Frequency | Once daily | Twice daily (or more) |
| Hypertension Dosing | 50-400 mg once daily | 25-100 mg twice daily |
| Heart Failure Dosing | Start at 12.5-25 mg once daily, target 200 mg once daily | Start at 6.25-12.5 mg twice daily, target 50 mg twice daily |
| Atrial Fibrillation | 50-400 mg once daily | 25-100 mg twice daily |
- The American College of Cardiology recommends starting at lower doses (12.5-25 mg once daily) and gradually titrating metoprolol succinate in elderly patients to avoid hemodynamic compromise, with a strength of evidence level of moderate 4
- The typical dosing for hypertension is 50-400 mg once daily for metoprolol succinate, and 25-100 mg twice daily for metoprolol tartrate, with a recommended initial dose of 12.5-25 mg once daily for metoprolol succinate and 6.25-12.5 mg twice daily for metoprolol tartrate, as advised by the American College of Cardiology and American Heart Association 5, 6, 7, 8, 9
Heart Failure Management Guidelines
- The American Heart Association, American College of Cardiology, and Heart Failure Society of America recommend metoprolol succinate extended-release with a target dose of 200mg once daily for heart failure management, corresponding to the total daily dose of metoprolol tartrate when given as 100mg twice daily, with a strength of evidence level of high 2
- Metoprolol succinate is specifically recommended in heart failure guidelines with a target dose of 200mg daily, and is one of only three beta-blockers proven to reduce mortality in heart failure patients, along with bisoprolol and carvedilol, as reported by the Circulation journal in 2005 1, 2, 4
- Metoprolol succinate has demonstrated a significant reduction in all-cause mortality in heart failure patients, with a 34% reduction in the MERIT-HF trial, as recommended by the American Heart Association and American College of Cardiology 4, 8, 10, 5
Special Considerations
- Women have higher exposure to CYP2D6-dependent beta-blockers, including metoprolol, due to lower volume of distribution and reduced metabolism, which may lead to increased adverse effects, and may benefit from lower-than-standard doses to reduce adverse drug reactions 11
- Elderly patients, particularly those in skilled nursing facilities, may be at increased risk for bradyarrhythmias during β-blocker therapy due to age-related changes in the conduction system, with a strength of evidence level of moderate 12
- Orthostatic hypotension may be reduced with metoprolol succinate's more stable plasma levels, but shorter-acting beta-blockers might be preferred for bedtime dosing to treat supine hypertension, with a strength of evidence level of low 13
- Regular assessment of heart rate, blood pressure, and symptoms is crucial, especially during initiation and dose adjustments, to minimize the risk of adverse effects and optimize treatment outcomes, as advised by the American Heart Association and American College of Cardiology 13, 9, 5
Discontinuation and Monitoring
- Gradual tapering of metoprolol is essential, with a recommended reduction in dose by half every week for 3 weeks, to avoid rebound symptoms such as angina, tachycardia, and hypertension, according to the American College of Cardiology and American Heart Association 9, 5
- Monitoring for rebound symptoms is necessary during tapering, as advised by the American Heart Association 9